Meeting Coverage

IGCS

International Gynecologic Cancer Society

FDA's Power Morcellator Warning Tied to Drop in Distant Leiomyosarcomas

Local and regional illness remained unchanged

IGCS over a photo of the Jacob K. Javits Convention Center in New York City

Latest IGCS Meetings

Pandemic Led to Surgical Delays in Gynecologic Cancers, and Worse Outcomes

One in five patients experienced changes in their care plan

October 4, 2022
Adding Chemo Not Better for Recurrent Endometrial Cancer

Trial suggests radiation therapy alone remains standard of care for pelvic-only recurrences

October 3, 2022
Durvalumab-CRT Pairing Disappoints in Locally Advanced Cervical Cancer

Still, CALLA trial findings "will inform future strategies to improve treatment," researcher says

October 2, 2022
Rucaparib a Winner for PFS, But Not for OS, in Recurrent Ovarian Cancer

PARP inhibitor still has value as maintenance therapy, ARIEL3 investigator says

October 1, 2022
'Potential Detrimental Effect' With Fourth-Line Olaparib in Ovarian Cancer

Post-hoc data from SOLO3 show diverging results based on prior lines of therapy

September 30, 2022